USPTO serial 97794244
VECTURA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- GLASSER, CARYN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VECTURA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tamar Niv Bessinger
Tamar Niv Bessinger FROSS, ZELNICK, LEHRMAN, & ZISSU, P.C151 WEST 42ND ST., 17TH FL.NEW YORK, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Bleaching preparations and other substances being laundry detergent for laundry use; cleaning, polishing, scouring and abrasive cleaning preparations, nonmedicated cosmetic soap, perfumery, essential oils, cosmetics, hair lotions, dentifrices, nonmedical oral hygiene preparations, namely mouthwashes, not for medical purposes; toothpaste; bath preparations, not for medical purposes | ACTIVE | — |
| 005 | Pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions, namely smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations for treatment of a wide variety of diseases and conditions, namely smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; vitamins and dietary supplements; dietetic foods adapted for medical purposes; nicotine chewing gum for use as an aid to stop smoking; medicated chewing gum; dietetic preparations for medical use; herbal extracts for medical purposes; herbal teas for medicinal purposes; air purifying preparations; aerosolized or inhaled therapeutics and pharmaceuticals namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders | ACTIVE | — |
| 009 | Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments, namely cameras and weighing scales; smartwatches; wearable activity trackers; wearable computers in the nature of smart-glasses used to monitor sleep, energy and stress; downloadable electronic books and magazines in the field of health, wellness, sleep, energy and stress; air analysis apparatus; recorded and downloadable media, namely podcasts and sound recordings featuring content concerning health, wellness, sleep, energy and stress; downloadable and recorded computer software platforms for wireless data communication for receiving, processing, transmitting and displaying information featuring content concerning health, wellness, sleep, energy and stress; downloadable computer software applications for wireless data communication for receiving, processing, transmitting and displaying information featuring content concerning health, wellness, sleep, energy and stress; downloadable computer programs for wireless data communication for receiving, processing, transmitting and displaying information featuring content concerning health, wellness, sleep, energy and stress | ACTIVE | — |
| 010 | Medical devices, namely inhalers for medical purposes, sold empty; medical devices for use for inhalation being inhalers sold empty; aerosol dispensers for medical purposes being inhalers for medical purposes, sold empty; dry powder inhalers (DPI) sold empty for medical purposes; nebulizers for medical purposes; pressurized metered-dose inhalers (pMDI) for medical purposes, sold empty; pulmonary drug delivery devices being delivery catheters, implantable drug delivery pumps, drug delivery patches sold without medication | ACTIVE | — |
| 030 | Coffee, tea, cocoa, sugar, rice, tapioca, sago, coffee substitutes and flour; food preparations of cereals being namely, cereal bars, cereal-based snack food and high protein cereal bars; bread, pastry and confectionery made of sugar; non-medicated chewing gum; ice cream; honey; yeast; baking powder; salt; mustard; vinegar, including wine vinegar, sauces, spices, raw ice being ice | ACTIVE | — |
| 041 | Education, namely, providing of training in relation to pharmaceuticals, drug delivery devices, healthcare and wellbeing | ACTIVE | — |
| 042 | Scientific and technological services namely research and design in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; medical research services; scientific research services; pharmaceutical development services; formulation being research, and development of inhaled therapeutics; formulation being research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems | ACTIVE | — |
| 044 | Medical services; medical services in the area of inhaled therapeutics and medical and pharmaceutical consultation in the field of pharmaceuticals and in the area of oral administration of pharmaceuticals; dietary and nutritional advice; health care services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vectura Fertin Pharma, Inc.
- Other trademarks owned by Vectura Fertin Pharma, Inc.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 030
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named VECTURA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 28, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 28, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 24, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 30, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 30, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 10, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 20, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 20, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 20, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 20, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 20, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 27, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 27, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 27, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 15, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 14, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Feb 14, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Nov 14, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 22, 2023 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jun 22, 2023 | ALIE | ASSIGNED TO LIE | — |
| Mar 4, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 23, 2023 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 17, 2023 | NWAP | NEW APPLICATION ENTERED | — |